JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Dentistry Section DOI : 10.7860/JCDR/2019/40070.12908
Year : 2019 | Month : Jun | Volume : 13 | Issue : 06 Full Version Page : ZC07 - ZC12

Comparative Evaluation of Colony Forming Units of Candida After Using Plain and Probiotic Added Denture Adhesive in Completely Edentulous Patients: A Randomised Crossover Trial

Tamanna Chhabra1, Vandana Shah2, Rajesh Sethuraman3

1 Professor, Department of Prosthodontics, K M Shah Dental College and Hospital, Sumandeep Vidyapeeth, Vadodara, Gujarat, India.
2 Professor and Head, Department of Oral Pathology, K M Shah Dental College and Hospital, Sumandeep Vidyapeeth, Vadodara, Gujarat, India.
3 Professor and Head, Department of Prosthodontics, K M Shah Dental College and Hospital, Sumandeep Vidyapeeth, Vadodara, Gujarat, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Tamanna Chhabra, D-8, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara, Gujarat, India.
E-mail: drtamannachhabra@gmail.com
Abstract

Introduction

Completely edentulous patients who wear dentures are more prone to candidiasis, under certain special conditions like compromised immunity. Besides that, if denture adhesives are also being used and hygiene maintenance is not carried out properly, because of decreased ability of senile patients, the risk factor surmounts. Such situations can be controlled with use of adhesives with anticandidal activity. Therefore, the present study was carried out to develop and evaluate a new combination of denture adhesives with Probiotics.

Aim

To evaluate the Colony Forming Units (CFU) of candida after using plain and probiotic added denture adhesive in completely edentulous patients.

Materials and Methods

At first, the stability testing for the new product which is a combination of probiotics and denture adhesives was done . The CFU/mL of candida was counted at the baseline and the participants were divided into two groups based on application of plain (group A) and probiotics added adhesives (Group B). The CFU was counted before and after crossover of patients to either group. The statistical tests used were descriptive statistics, repeated measures ANOVA and Bonferroni test for pair-wise comparison of CFU/mL.

Results

The stability test showed that the novel combination was stable for three months. The results revealed a statistically significant decrease in CFU/mL of candida from baseline to post intervention group B (p≤0.001), and after crossover of participants from Group A to Group B. (p≤0.01).

Conclusion

Therefore, it can be concluded that probiotics can play a significant role in decreasing the amount of candida in edentulous patients.

Keywords

Introduction

Probiotics are live micro-organisms which upon ingestion result in health benefits in the host. The term probiotic was coined in 1965 by Lilly and Stillwell [1]. Probiotics are ingested through food supplements like pharmaceuticals, dairy products, fruit juices etc.

Randomised clinical trials have already shown that these bacteria can be used as preventive and therapeutic agents for gastro intestinal ailments and vaginal infections in the host [2, 3].

These bacteria competitively grow and inhibit the harmful bacterias in the oral cavity causing caries, periodontal problems, and yeast infections. Studies have also proved that the probiotics effectively modulate the immune response and secrete antimicrobial substances to curb the pathogenic bacteria growing intraorally [4]. The benefits of the probiotic bacteria are strain specific, therefore a combination of strains are preferred. Most commonly used strains are Lactobacillus and Bifidobacterium [5].

Advantages of probiotics include improvement in the gastrointestinal system improving the overall health of the host. Probiotics, therapeutically combat diarrhea in children, relieve lactose intolerance and inflammatory bowel disease. They have been suggested as a preventive measure for colorectal cancer, regulatory means for blood pressure and suppressing cholesterol levels. Despite being strongly recommended with proven benefits, they are contraindicated in patients who are allergic to specific strains or lactose intolerance, and cardiac valve disease. There are not many disadvantages of probiotics other than sporadic gastrointestinal symptoms, systemic infections, excessive immune stimulation in susceptible individuals and gene transfer [6].

Candidiasis of oral cavity in denture wearers is common especially in palatal region, if the dentures are worn for longer period of time [7]. Once the patients are infected by candida, antifungal therapy is started which has deleterious side effects on gastro intestinal system. [8]

Therefore, much research has been dedicated towards preventing the colonisation of candida on the surfaces of denture and mucosal surfaces [9]. Antifungal denture forming materials are underway to prevent candidiasis [10]. Between the searches, Probiotics have emerged as a boon to dentistry. Probiotics have shown benefit when used systemically as well as used intra- orally in geriatric patients [11]. Research has increased in this direction of utilising the inherent antifungal and antibacterial properties of probiotics, when used locally in the oral cavity [12].

Denture adhesives play a supplemental role in increasing the retention and stability of dentures in edentulous patients. Not only in compromised situations but in well- formed ridges where patients expectations from the prosthesis are too high [13] . These products are bought over-the-counter and sometimes clinically indicated, therefore they are used widely by the patients.

Many times completely edentulous patients, even after receiving a well-made prosthesis are not satisfied with its retention and stability [14]. The conditions like highly resorbed ridges, very high mucosal attachments, flabby ridges, inability to utilise the neuromuscular control to hold the denture due to muscular disorders, or unable to visit the dentist for fabrication of a new denture due to senility are situations where the retention and stability are compromised [15]. In such situations, fabricating implant supported dentures may provide the necessary retention and stability expected from the prosthesis [16]. But at times due to systemic conditions and economic constraints of the patient, it is not feasible to fabricate such a prosthesis. In such situations, denture adhesives can play an important role in the retention of the prosthesis [17].

Along with the use of adhesives, denture hygiene maintenance is of prime importance. The lack of hygiene maintenance, propagates the opportunistic behaviour of candida causing Denture stomatitis. Therefore this study was planned to evaluate the effect of probiotics when used along with Denture adhesives on colony forming units of candida in denture wearing patients. For this purpose the probiotics were added to denture adhesives and this product was tested for its stability. The aim of the study was to evaluate and compare the colony forming units of candida, after using plain and probiotic added denture adhesive, in denture wearing patients. Null hypothesis of the study was that, there was no difference in colony forming unit of candida after using plain and probiotic added denture adhesive.

Materials and Methods

The study was a double-blind randomised clinical crossover trial conducted at Department of Prosthodontics, K M Shah Dental College and Hospital, on completely edentulous patients visiting the OPD. According to the patient enrollment, the study was conducted over six months i.e. March 2017 to August 2017.

The sample size of the study (n) was calculated based on the number of completely edentulous patients reporting per month to the department OPD (N) after using the formula:

n=N/1+Ne2

where N is Population size and e is the level of precision. If N is 60 for a month and e is 0.05. Hence, n was calculated to be 52. To take into the account the dropout rate of 20% as it is clinical trial, therefore n becomes 65. The power of the study was 80% with level of significance 0.05 and 95% confidence interval.

The inclusion criteria for the study was completely edentulous patients who were asymptomatic candida carriers with no candida infection, who were not on any antibiotics, probiotics or antifungal treatment. Patients with lactose intolerance, patients suffering from chronically debilitating disorder including gastrointestinal disorders, heart ailments, intolerance to milk and any patient who were not willing to be part of the study were excluded.

The ethical clearance for the study was obtained from institutional ethics committee and the study was registered with CTRI with Reg no. CTRI/2017/04/008314. Informed consent was obtained and patient information sheet was given to the participants of the study.

Adhesive Formulation

The adhesive was manufactured specially for the study which did not contain any preservatives or antimicrobials {Lot No.RD/FX 04}. Three strains of probiotic bacteria L.rhamnosus HS111, L. acidophilus HS101, and Bifidobacteriumbifidum were purchased from the manufacturers of probiotics (Mitushi Pharmaceuticals, Batch No.PBR1504130). The strength of the probiotic mix was kept at 108CFU. 3 gms of probiotic powder was added to 15 gm of denture adhesive. (Fixon, brand ICPA Health Product Ltd., GIDC, Ankleshwar, Gujarat). The viability of the probiotics was tested by the manufacturer of the denture adhesive (ICPA) according to ICH guidelines [18] [Table/Fig-1].

Stability test data for the combination of adhesive and probiotic.

ICPA Health Products Limited 286/287, GIDC, Ankleshwar-393002
Department: Research and DevelopmentFormat No.: RD/SP/052/A2
Stability study data
Product: Probiotic Mucoadhesive powderB.No.: RD_FX_02Pack size: 15 g PET bottlesMfg. Date: 9.10.2015Packaging Date: 9.10.2015Batch Size:100 g Label claims: 15% of blends of Lactobacilus acidophilus, Lactobacilus rhammosus, Bifidobacetrium bifidum. Storage condition: As per SOP No.RD/SP/52R1.Test Method: As per RD/SS/BP/13/10
TestprotocolLimitsInitialCONDITIONS1 M2 M3 M
DescriptionAn off white free flowing fine powder having characteristic flavorAn off white free flowing fine powder having characteristic flavor25±2°C/65±5 %RHOKOKOK
30±2°C/65±5 %RHOKOKOK
40±2°C/75±5 %RHOKOKOK
Total Probiotic count4 to 6 CFU5 CFU25±2°C/65±5 %RH432
30±2°C/65±5 %RH422
40±2°C/75±5 %RH422
Adhesion power3.5 to 6.0 kg4.6 kg25±2°C/65±5 %RH4.54.54.3
30±2°C/65±5 %RH4.64.34.2
40±2°C/75±5 %RH4.44.34.1

The study being double-blind RCT, the principal investigator and the patient were kept blinded to the study. Principal investigator was blinded as the entire allocation and assignment of intervention of the participants was carried by the staff nurse. Each patient received an identification number and was randomly allocated to 1 of the 2 intervention groups. Computer generated random numbers was used for random allocation. Allocation concealment of the assigned intervention was done with use of similar appearing bottles of adhesives. Staff nurse enrolled the participants and assigned them to their respective interventions. Codes were sealed in opaque envelop and decoded at the time of statistical evaluation.

Trained operators performed the procedure of fabricating the complete denture prosthesis. [Table/Fig-2] shows the flow diagram of the study.

Flow diagram of the study

Before recruitment of the participants they were evaluated for CFU/mL of candida after taking the palatal swab, if found asymptomatic (2-888 CFU/mL) they were enrolled in the study. [19]. This count of CFU/mL obtained for the first time, was recorded as the Baseline Data.

The entire Baseline observations for CFU of candida were made before the denture insertion. A palatal swab was obtained from each participant by rubbing a swab for 10 seconds on the palatal mucosal surface. The swab was serially diluted in phosphate- buffered saline and inoculated on the surface of Sabouraud Dextrose Agar (SDA) plates with 100 mg chloramphenicol/. After incubation for 24 to 48 hours, colonies were counted, and the number of CFU/mL was determined with Digital colony counter [20].

After recruitment of the patients at the baseline, according to inclusion and exclusion criteria, they were randomly allocated to the two groups.

Group A received a regular denture adhesive in powder form and the other Group B received a probiotic added denture adhesive in the powder form as well, at the time of insertion of the denture. Each participant was taught to sprinkle the provided denture adhesive five times on the intaglio surface of the maxillary and mandibular denture on each application from the bottle. Adhesive was supposed to be applied three times a day for five weeks. A count of five sprinkles was decided upon to regularise the amount of powder sprinkled by the participant each time. Participants were recalled after five weeks and second time palatal swab was taken again for counting the CFU of Candida.

After a wash out period of one week, a crossover of patients was done. Participants in group A were crossed over to Group B and vice versa. After a 5-week experimental period, participants were recalled and analysed for CFU/mL for the third time.

Statistical Analysis

Statistical test applied were descriptive statistics, Repeated Measures ANOVA, Bonferroni adjustment for Pairwise comparison among the groups using SPSS Version 21. The parameter to be evaluated was CFU/mL at baseline and in each group.

Results

The present study enrolled 65 edentulous patients aged 60 years and above of which 25% were females. The baseline demographic and clinical characteristic are shown in [Table/Fig-3]. 32 patients were randomly allocated to Group A after denture insertion who were supposed to use plain adhesive and 33 patients were given probiotic added adhesive for 5 weeks. Two patients were lost to follow-up after first recall due to ill health. Patients were evaluated for CFU/mL after taking palatal swab of the patient.

Baseline demographic and clinical characteristics.

Age60-7070-8080 and above
68%26%6%
SexMalesFemales
75%25%
Previous denture useLess than 5 years5-10 yearsNew denture
20%23%57%
Denture hygienePoorFairSatisfactory
7%46%47%
CFU/mL0-2020-40
83%17%

After a wash out period of one week, a cross-over of the patients was done to either group again for five weeks. At recall the CFU/mL of the patients were evaluated. Another 11 patients were lost to follow-up due to health condition or being out of station. At the baseline, data varied from 10 to 110 with a mean of 59.56±34.36. In group A with plain adhesive, the CFU/mL varied from 20 to 150 with a mean of 70.94±33.56. In Group B, with probiotic added denture adhesive, CFU/mL ranged from 8 to 96, a mean of 51.07±26.85. [Table/Fig-4]. The mean CFU/mL showed marked reduction in probiotic added denture adhesive. Data tabulated pre cross over for Group A and Group B is shown in [Table/Fig-5]. After crossover of the patients and considering the loss to follow-up, the data is shown in [Table/Fig-6]. [Table/Fig-7] shows Mauchly’s Test of Sphericity indicating the assumption of sphericity is fulfilled, χ2 (2)=1.023, p<0.05, and therefore, a Greenhouse-Geisser correction was used. There was a significant effect of different interventions in the form of plain adhesive and probiotic added adhesive in the Colony forming units, F=58.090, p<0.001.

Descriptive Statistics of the CFU/mL among the three groups.

Descriptive statistics
GroupsNMinimumMaximumMeanStd. deviation
CFU/mL at Baseline6510.00110.0059.563634.36016
CFU/mL with plain adhesive (Group A)5820.00150.0070.945533.56443
CFU/mL with probiotic added adhesive (Group B)578.0096.0051.072726.85962

Precross over CFU/mL in Group A and Group B.

Descriptive statistics
NMinimumMaximumMeanStd. deviation
CFU/mL with plane adhesive3222.00120.0067.093831.50152
CFU/mL with probiotic added adhesive318.0096.0049.156328.06572

Post cross ove rCFU/mL in Group A and Group B.

Descriptive statistics
NMinimumMaximumMeanStd. deviation
CFU/mL with plane adhesive2622.00120.0065.384631.39054
CFU/mL with probiotic added adhesive2610.0096.0049.923127.65201

Repeated measures of ANOVA with Mauchly’s analysis.

Repeated measures ANOVA
Within subjects effectMauchly’s WApprox. Chi-square (df, pvalue)Greenhouse-Geisser
Type III sum of squaresDfFp-value
Colony_Forming_Units.9811.023 (2, 0.600)10937.0551.96258.090≤0.001

Dextrose agar plates at baseline, Group A and Group B of the same patient are shown in [Table/Fig-8]. The Bonferroni Adjustment for the CFU/mL among the three groups show that there was no statistically significant reduction in CFU/mL between baseline and when plain adhesive is used. The mean difference, however, in these two stages was high showing that there is an increase in CFU/mL when plain adhesive is used compared to CFU/mL at baseline by 11.382. The difference between CFU/mL was found to be statistically significant in cases where probiotic is added in the adhesive as the p value is less than 0.001. As seen in [Table/Fig-9], the mean difference between these two groups was 19.873, which shows that the reduction in CFU/mL after adding probiotic in adhesive was also statistical significant from CFU/mL when plain adhesive was used. Similar statistically significant result was also observed between the CFU at baseline and when probiotic is added in adhesive. The mean difference between the CFU/mL at baseline and when probiotic is added to the adhesive was 8.491, which was also statistically significant having p<0.05.

Colony forming unit of candida at baseline, with plane adhesive and probiotic added adhesive.

Shows the results for Bonferroni adjustment showing the Pair wise Comparisons in three groups (*denotes that these values are considered significant at 0.05 level).

Pair wise comparison of the three groups
(I) Colony_Forming_Units(J) Colony_Forming_UnitsMean difference (I-J)Std. errorp-value95% Confidence interval for difference
Lower boundUpper bound
CFU/mL at BaselineCFU/mL with plane adhesive (Group A)-11.382*1.9200.345-16.125-6.638
CFU/mL with probiotic added adhesive (Group B)8.491*1.906≤0.0013.78113.200
CFU/mL with plane adhesive (Group A)CFU/mL at Baseline11.382*1.920.3456.63816.125
CFU/mL with probiotic added adhesive (Group B)19.873*1.718≤0.00115.62824.117
CFU/mL with probiotic added adhesive (Group B)CFU/mL at Baseline-8.491*1.906≤0.001-13.200-3.781
CFU/mL with plane adhesive (Group A)-19.873*1.718≤0.001-24.117-15.628

Discussion

Candida being a commensal in the oral cavity turns into an opportunist due to various supporting factors. Age and diminishing immunity, improper oral hygiene, systemic disorders being few among the factors. Patients with complete denture prosthesis always show tendency to develop denture stomatitis when they are not able to maintain the prosthesis [21]. The situation may worsen with adhesives use, when added as a layer on the dentures to improve its function [22]. Once the patients suffers from candidiasis, irrational use of antifungals lead to various side effects like Gastrointestinal problems [8]. Therefore, this study was planned to evaluate the effect of Probiotics when used locally with the denture adhesives on colony forming units of candida in the oral cavity of a denture wearer.

Probiotics are living microorganisms when ingested in appropriate strengths bring positive health changes in the host. Probiotics have proved to be beneficial against the pathogenic bacteria and genus Candida in oral cavity [23]. There are several mechanisms by which these noble bacteria hinder the growth of the pathogens. A few mechanism are by competing, antagonising, and altering immune response of the host. Evidence suggesting protective role of probiotics on elderly individuals allow their use in topical applications and various formulations to treat oral diseases [11]. Hence the following study was carried out to evaluate the combination of probiotics added to Denture Adhesives.

Denture Adhesives have been used over the years now to enhance the stability and retention of dentures [24]. They are short and long acting synthetic polymers. Molecules of adhesives swell up to fill the spaces between denture and mucosa. They also increase the cohesive force by increasing the interfacial tension when the denture is tried to be pulled away from mucosa. Evidence has shown that the adhesives are beneficial under many circumstances [25]. Not only are they effective in poor ridge cases but also in good ridges. On one hand they improve the retention and stability of denture in a poor ridge cases and on the other hand it improves satisfaction in well-built ridges. Adhesives can also be utilised as a means to improve retention in poor muscular control due to nerve damage in stroke or chronic debilitating disorders. Denture adhesives provides the necessary lubrication in aged thin mucosa, preventing abrasion and entry of food particles beneath it. Not only objective measures like quality of life studies but also objective measures like kinesiographic studies and electromyographic studies have also proved that denture adhesives enhance the retention and stability of the dentures [26]. Evidence based guidelines state the judicious use of adhesives is beneficial to the denture wearers [27].

Studies have shown that the colony forming units of candida does not increase after using adhesives [28]. Though few studies reported that adhesives can increase the number of candida infection in the mouth. The results of this study are similar to the studies done earlier where there is no statistically significant increase in colony forming units of candida (.345) from baseline to using adhesives. A small amount of increase in candida depends upon how well the patients practice hygiene. The colony forming units may increase even if small adhesive remains stuck to the intaglio surface of denture [29]. The colony forming unit of candida decreased after probiotics are added to denture adhesives as seen in the present study [Table/Fig-4].

The probiotics act on pathogens by several mechanisms for the advantage of the host [30].

They enhance the host defence by increasing their immunity against the pathogens. Studies show that probiotics help friendly bacteria to rise in number [31]. They release certain chemicals like organic acids, hydrogen peroxide, and bacteriocins [32]. The precise mechanism by which this occurs is still being studied. Probiotic bacteria hinder the survival of the pathogens and affect their virulence on the host [33]. They compete for nutrients and adhesion sites with the pathogens on the host, thereby directly affecting their pathogenicity [34]. Pathogens harm the host by forming a biofilm on its surface, which is also deterred by probiotic bacteria [35]. Murzyn A et al., have inferred that Capric acid is the main product that hinders hyphae formation in the yeast [36]. Kohler GA et al., concluded that lactic acid at low pH affect biofilm formation [37]. According to Kheradmand E et al., the release of exometabolites hinders candida growth [38]. Ujaoney carried an in vitro study and stated that the lack of nutrients for candida due to overgrowth of probiotic bacteria prove harmful for candida growth [39].

Similarly there are some of clinical studies which have yielded similar results as obtained in this study. Mendonca FH did a study on women, the results showed 92.9 to 85% reduction in candida after using probiotics [40]. Studies conducted by Hatakka K and Ishikawa KH have shown in their studies that how oral intake and local application of probiotics reduce amount of CFU/mL in the oral cavity [11,20].

Matsubara VH et al., conducted a study to understand the mechanism of action of the probiotics in altering the host immunity [35]. They studied that how the expression of pattern-recognition receptors genes is altered (CLE7A, TLR2, and TLR4) with probiotic treatment. Macrophages which were treated with probiotics showed lesser production of Dectin-1. The lactate released by lactic acid bacteria (LAB) interferes with purpose of macrophages and dendritic cells and alters the inflammatory response of epithelial cells.

According to the results of the study, it can be inferred, the probiotics can alter the host immunity and decreases the number of candida in the oral cavity even in asymptomatic candida carriers. Therefore probiotics can have prophylactic effect in patients who are prone to suffer from oral candidiasis and can also be used as an adjuvant in therapy of people suffering from oral thrush. The new combination of probiotics added to denture adhesives if used can serve as a boon for the completely edentulous patients, utilising the advantages of both the products together.

In the present study, regular calls were made to the patients enrolled for the study to make sure that the patients were following the instructions given regarding use of Denture adhesives and would return for follow-up.

Limitation

The limitations of the study was that the stability of the novel combination was tested for just three months only and further studies are required to check the stability of this combination with different range of probiotics and strengths. Also studies need to be carried out in symptomatic patients to assess and compare the efficacy of plain and probiotic added denture adhesive.

This further has the advantage, that the product will not be overly used for a long period of time, as evidence based guidelines studies suggest the use of Denture adhesives for two to three months. Probiotics have the inherent nature of becoming nonviable at higher temperatures and storage conditions.

Conclusion

Within the limitations of the study, it can be concluded that a combination of Denture adhesive and probiotics can be formulated which is stable for three months. Also, the product when used by completely edentulous patients can help in reducing candida. It can be used as an adjuvant to therapeutic measures and as an preventive means to reduce the risk of contacting candidiasis.

References

[1]Lilly DM, Stillwell RH, Probiotics growth-promoting factors produced by microorganisms Science 1965 147(3659):747-48.10.1126/science.147.3659.74714242024  [Google Scholar]  [CrossRef]  [PubMed]

[2]Ruszczynski M, Radzikowski A, Szajewska H, Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children Aliment Pharmacol Ther 2008 28(1):154-61.10.1111/j.1365-2036.2008.03714.x18410562  [Google Scholar]  [CrossRef]  [PubMed]

[3]Russo R, Karadja E, De Seta F, Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial Benef microbes 2019 10(1):19-26.10.3920/BM2018.007530525953  [Google Scholar]  [CrossRef]  [PubMed]

[4]Van Niel CW, Probiotics: not just for treatment anymore Pediatrics 2005 115(1):174-77.10.1542/peds.2004-235615629997  [Google Scholar]  [CrossRef]  [PubMed]

[5]Stamatova I, Meurman JH, Probiotics: Health benefits in the mouth Am J Dent 2009 22:329-38.  [Google Scholar]

[6]Ayichew T, Belete A, Alebachew T, Tsehaye H, Berhanu H, Bacterial Probiotics their Importances and Limitations: a Review J Nutr Health Sci 2017 4(2):20210.15744/2393-9060.4.202  [Google Scholar]  [CrossRef]

[7]McMullan-Vogel C, Jude H, Ollert M, Vogel C, Serotype distribution, and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis Oral Microbiol Immunol 1999 14(3):183-89.10.1034/j.1399-302X.1999.140307.x10495713  [Google Scholar]  [CrossRef]  [PubMed]

[8]Oliver RJ, Dhaliwal HS, Theaker ED, Pemberton MN, Patterns of antifungal prescribing in general dental practice Br Dent J 2004 196(11):701-03.10.1038/sj.bdj.481135415192736  [Google Scholar]  [CrossRef]  [PubMed]

[9]Grzech-Leśniak K, Nowicka J, Matys J, Pajaczkowska M, Szymonowicz M, Kuropka P, Effects of Nd:YAG laser irradiation on the growth of Candida albicans and Streptococcus mutans: in vitro study Lasers Med Sci 2019 34(1):129-37.10.1007/s10103-018-2622-630145724  [Google Scholar]  [CrossRef]  [PubMed]

[10]Nam K, Lee C, Lee C, Antifungal and physical characteristics of modified denture base acrylic incorporated with silver nanoparticles Gerodontology 2012 29(2):e413-e419.10.1111/j.1741-2358.2011.00489.x22612845  [Google Scholar]  [CrossRef]  [PubMed]

[11]Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Probiotics reduce the prevalence of oral Candida in the elderly-a randomized controlled trial J Dent Res 2007 86(2):125-30.10.1177/15440591070860020417251510  [Google Scholar]  [CrossRef]  [PubMed]

[12]Sookkhee S, Chulasiri M, Prachyabrued W, Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens J App Microbiol 2001 90(2):172-79.10.1046/j.1365-2672.2001.01229.x  [Google Scholar]  [CrossRef]

[13]Adisman IK, The use of denture adhesive as an aid to denture treatment J Prosthet Dent 1989 62(6):711-15.10.1016/0022-3913(89)90598-2  [Google Scholar]  [CrossRef]

[14]Munoz CA, Gendreau L, Shanga G, Magnuszewski T, Fernandez P, Durocher J, A clinical study to evaluate denture adhesive use in well-fitting dentures J Prosthodont 2012 21(2):123-29.10.1111/j.1532-849X.2011.00795.x22054033  [Google Scholar]  [CrossRef]  [PubMed]

[15]Shay K, The retention of complete dentures. In Zarb GA, Bolender CL (eds) Prosthodontic Treatment for Edentulous Patients 2004 ed 12St. LouisMosby:437-48.  [Google Scholar]

[16]Abdelaal NA, Metwally AF, Evaluation of mini-implant-retained overdentures on the electromyographic activity and patients’ satisfaction in completely edentulous patients (randomized clinical trial) Int Dent Med J Adv Res 2017 3:1-4.10.15713/ins.idmjar.79  [Google Scholar]  [CrossRef]

[17]Grasso JE, Denture adhesives: changing attitudes J Am Dent Assoc 1996 127(1):90-6.10.14219/jada.archive.1996.00368568103  [Google Scholar]  [CrossRef]  [PubMed]

[18]Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf (last accessed on: 10th April 2019)  [Google Scholar]

[19]Zhou PR, Hua H, Liu XS, Quantity of Candida colonies in saliva: a diagnostic evaluation for oral candidiasis Chin J Dent Res 2017 20(1):27-32.  [Google Scholar]

[20]Ishikawa KH, Mayer MP, Miyazima TY, Matsubara VH, Silva EG, Paula CR, A multispecies probiotic reduces oral Candida colonization in denture wearers J Prosthodont 2015 24(3):194-99.10.1111/jopr.1219825143068  [Google Scholar]  [CrossRef]  [PubMed]

[21]Gendreau L, Loewy ZG, Epidemiology, and Etiology of Denture Stomatitis J Prosthodont 2011 20:251-60.10.1111/j.1532-849X.2011.00698.x21463383  [Google Scholar]  [CrossRef]  [PubMed]

[22]Gates WD, Goldschmidt M, Kramer D, Microbial contamination in four commercially available denture adhesives J Prosthet Dent 1994 71(2):154-8.10.1016/0022-3913(94)90024-8  [Google Scholar]  [CrossRef]

[23]Tarbet WJ, Boone M, Schmidt NF, Effect of a denture adhesive on complete denture dislodgement during mastication J Prosthet Dent 1980 44(4):374-8.10.1016/0022-3913(80)90092-X  [Google Scholar]  [CrossRef]

[24]Kapur KK, A clinical evaluation of denture adhesive J Prosthet Dent 1967 18:550-8.10.1016/0022-3913(67)90221-1  [Google Scholar]  [CrossRef]

[25]Gonçalves TM, Viu FC, Gonçalves LM, Garcia RC, Denture adhesives improve mastication in denture wearers Int J Prosthodont 2014 27(2):140-46.10.11607/ijp.367424596911  [Google Scholar]  [CrossRef]  [PubMed]

[26]Psillakis JJ, Wright RF, Grbic JT, Lamster IB, In practice evaluation of a denture adhesive using a gnathometer J Prosthodont 2004 13(4):244-50.10.1111/j.1532-849X.2004.04040.x15610546  [Google Scholar]  [CrossRef]  [PubMed]

[27]Felton D, Cooper L, Duqum I, Minsley G, Guckes A, Haug S, Evidence-based guidelines for the care and maintenance of complete dentures: a publication of the American College of Prosthodontists J Am Dent Assoc 2011 142:1S-20S.10.14219/jada.archive.2011.0067  [Google Scholar]  [CrossRef]

[28]Ozkan YK, Uçankale M, Özcan M, Üner N, Effect of denture adhesive on the micro-organisms in vivo Gerodontology 2012 29(1):09-16.10.1111/j.1741-2358.2010.00381.x22098056  [Google Scholar]  [CrossRef]  [PubMed]

[29]Sanders ME, Klaenhammer TR, Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic J Dairy Sci 2001 84(2):319-31.10.3168/jds.S0022-0302(01)74481-5  [Google Scholar]  [CrossRef]

[30]Rizzo A, Fiorentino M, Buommino E, Donnarumma G, Losacco A, Bevilacqua N, Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro Int J Med Microbiol 2015 305(8):815-27.10.1016/j.ijmm.2015.07.00526372530  [Google Scholar]  [CrossRef]  [PubMed]

[31]Matsubara VH, Bandara HM, Mayer MP, Samaranayake LP, Probiotics as antifungals in mucosal candidiasis Clin Infect Dis 2016 62(9):1143-53.10.1093/cid/ciw03826826375  [Google Scholar]  [CrossRef]  [PubMed]

[32]Ribeiro FC, de Barros PP, Rossoni RD, Junqueira JC, Jorge AO, Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella J Appl Microbiol 2017 122(1):201-11.10.1111/jam.1332427727499  [Google Scholar]  [CrossRef]  [PubMed]

[33]Wang S, Wang Q, Yang E, Yan L, Li T, Zhuang H, Antimicrobial compounds produced by vaginal Lactobacillus crispatus are able to strongly inhibit Candida albicans growth, hyphal formation and regulate virulence-related gene expressions Front Microbiol 2017 8:56410.3389/fmicb.2017.00564  [Google Scholar]  [CrossRef]

[34]Matsubara VH, Wang Y, Bandara HM, Mayer MP, Samaranayake LP, Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation Appl Microbiol Biotechnol 2016 100(14):6415-26.10.1007/s00253-016-7527-327087525  [Google Scholar]  [CrossRef]  [PubMed]

[35]Matsubara VH, Ishikawa KH, Ando-Suguimoto ES, Bueno-Silva B, Nakamae AE, Mayer M, Probiotic Bacteria Alter Pattern-Recognition Receptor Expression and Cytokine Profile in a Human Macrophage Model Challenged with Candida albicans and Lipopolysaccharide Front Microbiol 2017 8:228010.3389/fmicb.2017.0228029238325  [Google Scholar]  [CrossRef]  [PubMed]

[36]Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M, Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion, and biofilm formation PloS One 2010 5(8):e1205010.1371/journal.pone.001205020706577  [Google Scholar]  [CrossRef]  [PubMed]

[37]Köhler GA, Assefa S, Reid G, Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans Infect Dis Obstet Gynecol 2012 2012:63647410.1155/2012/63647422811591  [Google Scholar]  [CrossRef]  [PubMed]

[38]Kheradmand E, Rafii F, Yazdi MH, Sepahi AA, Shahverdi AR, Oveisi MR, The antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicans Daru 2014 22(1):4810.1186/2008-2231-22-4824906455  [Google Scholar]  [CrossRef]  [PubMed]

[39]Ujaoney S, Chandra J, Faddoul F, Chane M, Wang J, Taifour L, In vitro effect of over-the-counter probiotics on the ability of Candida albicans to form biofilm on denture strips J Dent Hyg 2014 88(3):183-9.  [Google Scholar]

[40]Mendonça FH, Santos SS, Faria ID, Gonçalves E, Silva CR, Jorge AO, Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly Braz Dent J 2012 23(5):534-8.10.1590/S0103-6440201200050001123306230  [Google Scholar]  [CrossRef]  [PubMed]